Literature DB >> 6446522

Review of the role of the central serotonergic neuronal system in blood pressure regulation.

D M Kuhn, W A Wolf, W Lovenberg.   

Abstract

Alterations in the dynamics of brain serotonin biosynthesis can lead to changes in cardiovascular function. It appears that the activation of cerebral serotonin receptors produces a pressor effect in normotensive rats but produces a depressor effect in normotensive cats or dogs. On the other hand, reductions in the levels of serotonin can prevent the onset of hypertension in some experimental hypertensive models and lower the blood pressure of organisms with established hypertension. The ability of brain serotonin to modulate arterial blood pressure may be mediated by the influences of the serotonergic neuronal systems on efferent sympathetic activity. Finally, the reduction in sympathetic outflow produced by increasing brain serotonin levels in dogs protects the heart against ventricular fibrillation and may, therefore, constitute a reasonable adjunct in the management of high-risk, cardiac-arrest patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6446522     DOI: 10.1161/01.hyp.2.3.243

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  36 in total

Review 1.  The potential role of serotonin in the pathogenesis of neurocardiogenic syncope and related autonomic disturbances.

Authors:  B P Grubb; B J Karas
Journal:  J Interv Card Electrophysiol       Date:  1998-12       Impact factor: 1.900

Review 2.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

Review 3.  The role of 5-hydroxytryptamine and 5-hydroxytryptaminergic mechanisms in hypertension.

Authors:  P A van Zwieten; G J Blauw; P van Brummelen
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

Review 4.  Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

Review 5.  Central serotonergic mechanisms in cardiovascular regulation.

Authors:  J Minson; J Chalmers; G Drolet; V Kapoor; I Llewellyn-Smith; E Mills; M Morris; P Pilowsky
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

6.  Enhanced 5-HT(2A) receptor status in the hypothalamus and corpus striatum of ethanol-treated rats.

Authors:  K G Akash; K S Balarama; C S Paulose
Journal:  Cell Mol Neurobiol       Date:  2008-04-19       Impact factor: 5.046

7.  Chemically defined collateral projections from the pons to the central nucleus of the amygdala and hypothalamic paraventricular nucleus in the rat.

Authors:  T Petrov; T L Krukoff; J H Jhamandas
Journal:  Cell Tissue Res       Date:  1994-08       Impact factor: 5.249

8.  Reduced urinary serotonin excretion after intake of high doses of hypoxanthine.

Authors:  H Manzke; H Gustmann
Journal:  Eur J Pediatr       Date:  1989-01       Impact factor: 3.183

9.  Decreased 5-HT1A receptor gene expression and 5-HT1A receptor protein in the cerebral cortex and brain stem during pancreatic regeneration in rats.

Authors:  Valiya veettil Mohanan; S Balarama Kaimal; Cheramadathikudyil S Paulose
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

10.  Reduced brain serotonergic activity after repeated treatment with beta-adrenoceptor antagonists.

Authors:  H Hallberg; O Almgren; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.